VORICONAZOLE
Generic: VORICONAZOLE
Xellia Pharmaceuticals USA LLCManufacturer
INTRAVENOUSRoute
VORICONAZOLEActive Substance
2017-03-09Original Approval
VORICONAZOLE is FDA application NDA208562, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-03-13
Voriconazole Tablets 50mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, MadhyCGMP Deviations
Class II2025-03-24
Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose percGMP Deviations: Received notification from their supplier requesting they perform a recall due to t
Class II2024-02-05
Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the bottLabeling: Incorrect or Missing Package Insert
Class II2025-03-13
Voriconazole Tablets 200 mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, MadCGMP Deviations
Top Reported Reactions
1
DRUG INEFFECTIVE
4,031 reports
2
OFF LABEL USE
2,121 reports
3
DRUG INTERACTION
2,063 reports
4
PYREXIA
1,074 reports
5
PNEUMONIA
911 reports
6
BRONCHOPULMONARY ASPERGILLOSIS
897 reports
7
CONDITION AGGRAVATED
879 reports
8
ASPERGILLUS INFECTION
866 reports
9
FEBRILE NEUTROPENIA
756 reports
10
DEATH
727 reports